DE1114188B - Verfahren zur Herstellung neuer Strophanthidol-glykoside - Google Patents
Verfahren zur Herstellung neuer Strophanthidol-glykosideInfo
- Publication number
- DE1114188B DE1114188B DEB55963A DEB0055963A DE1114188B DE 1114188 B DE1114188 B DE 1114188B DE B55963 A DEB55963 A DE B55963A DE B0055963 A DEB0055963 A DE B0055963A DE 1114188 B DE1114188 B DE 1114188B
- Authority
- DE
- Germany
- Prior art keywords
- strophanthidol
- glycosides
- new
- production
- strophanthidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZNDMLUUNNNHNKC-HZXDTFASSA-N Strophanthidol Natural products C1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@H](O)C[C@@]5(O)CC4)CO)CC[C@@]32C)=CC(=O)OC1 ZNDMLUUNNNHNKC-HZXDTFASSA-N 0.000 title claims description 10
- 229930182470 glycoside Natural products 0.000 title claims description 9
- ZNDMLUUNNNHNKC-UHFFFAOYSA-N G-strophanthidin Natural products CC12CCC(C3(CCC(O)CC3(O)CC3)CO)C3C1(O)CCC2C1=CC(=O)OC1 ZNDMLUUNNNHNKC-UHFFFAOYSA-N 0.000 title claims description 7
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 238000000034 method Methods 0.000 title claims description 5
- -1 strophanthidol glycosides Chemical class 0.000 title claims description 5
- ODJLBQGVINUMMR-UHFFFAOYSA-N Strophanthidin Natural products CC12CCC(C3(CCC(O)CC3(O)CC3)C=O)C3C1(O)CCC2C1=CC(=O)OC1 ODJLBQGVINUMMR-UHFFFAOYSA-N 0.000 claims description 6
- 229960000648 digitoxin Drugs 0.000 claims description 5
- ODJLBQGVINUMMR-HZXDTFASSA-N strophanthidin Chemical compound C1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@H](O)C[C@@]5(O)CC4)C=O)CC[C@@]32C)=CC(=O)OC1 ODJLBQGVINUMMR-HZXDTFASSA-N 0.000 claims description 5
- WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- 150000002338 glycosides Chemical class 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 125000003172 aldehyde group Chemical group 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229930182478 glucoside Natural products 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000000075 primary alcohol group Chemical group 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- 241000700198 Cavia Species 0.000 description 1
- 241000919496 Erysimum Species 0.000 description 1
- HKNQDCBTAOHPIM-UHFFFAOYSA-N Helveticosid Natural products CC1OCC(CC(O)C1O)OC2CCC3(C=O)C4CCC5(C)C(CCC5(O)C4CCC3(O)C2)C6=CC(=O)OC6 HKNQDCBTAOHPIM-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000511943 Strophanthus Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002596 lactones Chemical group 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB55963A DE1114188B (de) | 1959-12-18 | 1959-12-18 | Verfahren zur Herstellung neuer Strophanthidol-glykoside |
| LU39458D LU39458A1 (enrdf_load_stackoverflow) | 1959-12-18 | 1960-11-25 | |
| CH1338460A CH397659A (de) | 1959-12-18 | 1960-11-30 | Verfahren zur Herstellung neuer Strophanthidol-glykoside |
| BE598191A BE598191A (fr) | 1959-12-18 | 1960-12-14 | Nouveaux glycosides de strophantidol et leur préparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB55963A DE1114188B (de) | 1959-12-18 | 1959-12-18 | Verfahren zur Herstellung neuer Strophanthidol-glykoside |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1114188B true DE1114188B (de) | 1961-09-28 |
Family
ID=6971164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEB55963A Pending DE1114188B (de) | 1959-12-18 | 1959-12-18 | Verfahren zur Herstellung neuer Strophanthidol-glykoside |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE598191A (enrdf_load_stackoverflow) |
| CH (1) | CH397659A (enrdf_load_stackoverflow) |
| DE (1) | DE1114188B (enrdf_load_stackoverflow) |
| LU (1) | LU39458A1 (enrdf_load_stackoverflow) |
-
1959
- 1959-12-18 DE DEB55963A patent/DE1114188B/de active Pending
-
1960
- 1960-11-25 LU LU39458D patent/LU39458A1/xx unknown
- 1960-11-30 CH CH1338460A patent/CH397659A/de unknown
- 1960-12-14 BE BE598191A patent/BE598191A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE598191A (fr) | 1961-06-14 |
| CH397659A (de) | 1965-08-31 |
| LU39458A1 (enrdf_load_stackoverflow) | 1961-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68906108T2 (de) | Ginkgo-biloba-extrakte und ihre verfahren zur herstellung. | |
| DE3688001T2 (de) | Fruchtbarkeitsmittel enthaltend extrakte von coix lacryma-jobi oder ferulylstanolderivate und/oder fettsaeure-phytosterolester. | |
| CH650931A5 (de) | Extrakt von zedrach borken mit geschwulsthemmender wirkung und verfahren zu dessen herstellung. | |
| DE1076888B (de) | Verfahren zur Gewinnung atmungsfoerdernder Wirkstoffe fuer therapeutische Zwecke | |
| DE1114188B (de) | Verfahren zur Herstellung neuer Strophanthidol-glykoside | |
| AT223746B (de) | Verfahren zur Herstellung neuer Strophanthidolglykoside | |
| DE876441C (de) | Verfahren zur Herstellung eines Wirkkoerpers aus Weissdorn | |
| EP0234019A1 (de) | Verwendung von wässrigen Auszügen von Epilobium angustifolium L. zu einer neuen medizinischen Indikation | |
| DE1468554C (de) | 20 beta tert Amino 3 alpha hydroxy (bzw acyloxy) 5 beta pregnane bzw de ren Salze sowie Verfahren zu ihrer Her stellung | |
| DE925374C (de) | Verfahren zur Gewinnung reiner Lipoide | |
| DE2147263C3 (enrdf_load_stackoverflow) | ||
| DE1467743A1 (de) | Verfahren zur Herstellung eines Praeparats mit verlaengerter Vitamin B 12-Wirkung | |
| AT200257B (enrdf_load_stackoverflow) | ||
| DE936592C (de) | Verfahren zur Herstellung eines blut- und harnzuckersenkenden Praeparates aus trioxyflavonglukosidhaltigen Pflanzenteilen | |
| DE2016704C3 (de) | Ein neues, herzwirksames 14,15 ß -Oxidobufadienolid-LRhamnosid und Verfahren zu seiner Herstellung | |
| DE1518141C3 (de) | Verfahren zur Herstellung eines Kon densationsproduktes aus einem Rohextrakt aus Podophyllum Rhizomen mit Benzaldehyd | |
| DE1667884C3 (de) | Verfahren zur Gewkinung von reinem Ae sein | |
| DE862938C (de) | Verfahren zur Herstellung von die Mobilisierung des Organglykogens bewirkenden Stoffen | |
| DE806879C (de) | Verfahren zur Anreicherung des Darmwirkstoffes aus tierischen Organen | |
| AT325783B (de) | Verfahren zum abtrennen des glykofrangulin-komplexes aus pflanzlichen rohstoffen, insbesondere aus der getrockneten rinde des faulbaumes | |
| DE566783C (de) | Verfahren zur Darstellung von Thelykininen | |
| DE1919852A1 (de) | 3beta-Diaethylaminoaethoxy-20-keto-delta?-pregnan und Verfahren zu seiner Herstellung | |
| DE1668239C3 (de) | Verfahren zur Gewinnung von reinem Acetyldigoxin in der alpha-Form | |
| DE1617667C (de) | Verfahren zur Gewinnung eines sennosidreichen Wirkstoffkonzentrates aus Sennesschoten | |
| DE1140315B (de) | Verfahren zur Herstellung von Digitoxin-Gitaloxin-Mischkristallisaten |